Tag Archives: Fresh trial launched for ‘COVID-19 drug’ in Japan

Fujifilm Holdings said on Wednesday it started a new phase III trial in Japan of its Avigan drug for COVID-19, reviving hopes for a home-grown treatment for the virus. Domestic approval for the antiviral drug to treat the coronavirus was dealt a setback in December after a health ministry panel said that trial data was inconclusive. Fujifilm has over the …

Read More »